Tag: Drugs (Pharmaceuticals)

Opioid Defendants Seek to Disqualify Judge Overseeing 2,300 Cases

Scarcely five weeks before a landmark federal civil trial in the opioid epidemic, the giant retail pharmacy chains and drug distributors that are defendants in the bellwether Ohio case are seeking to disqualify the judge from overseeing it and nearly 2,300 other opioid-related lawsuits before him. In a brief filed in federal court at 1:24 […]

Read More

Zantac Has Low Levels of a Cancer-Causing Chemical, the F.D.A. Says

The Food and Drug Administration said on Friday that it had detected low levels of a cancer-causing contaminant in samples of heartburn medicines containing the drug commonly known as Zantac, and that it was advising patients who take over-the-counter versions to consider switching to a different medication. But no recalls have been initiated, and the […]

Read More

Peanut Allergy Drug Will Protect Children, Experts Tell F.D.A.

The first-ever drug regimen to blunt acute peanut allergies in children should be approved, experts told a Food and Drug Administration committee on Friday, because the therapy has the potential to reduce the risk of life-threatening reactions and to improve patients’ lives. The new drug, called Palforzia and made by Aimmune Therapeutics, is an oral […]

Read More

Why Aren’t There Better Cancer Drugs? Scientists May Have Picked the Wrong Targets

Twenty years ago, the fight against cancer seemed as if it were about to take a dramatic turn. Traditionally, cancer doctors fought the disease with crude weapons, often simply poisoning fast-growing cells whether they were cancerous or healthy. But then a team of researchers hit on a new strategy: drugs targeting proteins produced by cancer […]

Read More

Purdue Pharma Settles Thousands of Opioids Cases

Purdue Pharma and its owners, members of the Sackler family, have tentatively reached the first comprehensive settlement with lawyers representing thousands of municipal governments, tribes and states nationwide that are suing the pharmaceutical industry for the devastation resulting from the opioid epidemic. The company is expected to file for Chapter 11 bankruptcy imminently. The settlement, […]

Read More

China Lifts Tariffs on Some U.S. Goods in Modest Olive Branch to Trump

BEIJING — Beijing extended a modest olive branch to President Trump on Wednesday amid the continuing trade war between the United States and China, publishing a short list of products to be spared from retaliatory tariffs on American-made goods. The list did not include major items like soybeans and other agricultural goods that the Trump […]

Read More

China Lifts Some U.S. Tariffs in Modest Olive Branch to Trump

BEIJING — China extended a modest olive branch to President Trump on Wednesday, publishing a short list of products that it will exempt from its retaliatory tariffs on American-made goods. But the list does not include big-ticket items, like soybeans and other agricultural goods, that the Trump administration would likely consider key to getting a […]

Read More

Pelosi Enlivens Battle to Lower Drug Prices

A draft proposal by Speaker Nancy Pelosi would empower the federal government to negotiate lower prices for hundreds of prescription drugs, not only for Medicare but for the private market as well, injecting new urgency into Washington’s efforts to control the soaring price of pharmaceuticals. The plan would revive an idea loathed by most congressional […]

Read More

Who’s Missing From Breast Cancer Trials? Men, Says the F.D.A.

In recent years, health officials have pushed aggressively to include more women in clinical trials of new drugs. Gone is the ban that once excluded women of childbearing age from participating in studies. Even scientists who work with animals are now encouraged to include mice and rats of both sexes. But when it comes to […]

Read More

These Newborn Babies Cry for Drugs, Not Milk

CHARLESTON, W.Va. — His body dependent on opioids, he writhes, trembles and cries. He is exhausted but cannot sleep. He vomits, barely eats and has lost weight. He is also a baby. Just 1 month old, he wails in the nursery of the CAMC Women and Children’s Hospital here. A volunteer “cuddler” holds him while […]

Read More

Major Opioid Maker Is Close to Settling Case to Avert First Federal Trial

One of the biggest makers of generic opioids in the United States has reached a tentative settlement of claims against it to avoid the first federal trial of drug makers, distributors and retail chains for their roles in the opioid epidemic. Mallinckrodt Pharmaceuticals announced Friday that it had agreed to pay $24 million to two […]

Read More

Tim Ferriss, the Man Who Put His Money Behind Psychedelic Medicine

The announcement on Wednesday that Johns Hopkins Medicine was starting a new center to study psychedelic drugs for mental disorders was the latest chapter in a decades-long push by health nonprofits and wealthy donors to shake up psychiatry from the outside, bypassing the usual channels. “Psychiatry is one of the most conservative specialties in medicine,” […]

Read More

Johns Hopkins Opens New Center for Psychedelic Research

Since childhood, Rachael Petersen had lived with an unexplainable sense of grief that no drug or talk therapy could entirely ease. So in 2017 she volunteered for a small clinical trial at Johns Hopkins University that was testing psilocybin, the active ingredient in magic mushrooms, for chronic depression. “I was so depressed,” Ms. Petersen, 29, […]

Read More

That Beloved Hospital? It’s Driving Up Health Care Costs

As voters fume about the high cost of health care, politicians have been targeting two well-deserved villains: pharmaceutical companies, whose prices have risen more than inflation, and insurers, who pay their executives millions in salaries while raising premiums and deductibles. But while the Democratic presidential candidates have devoted copious airtime to debating health care, many […]

Read More

Sacklers vs. States: Settlement Talks Stumble Over Foreign Business

Purdue Pharma’s negotiations to settle thousands of lawsuits over the company’s role in the opioids crisis have turned into a standoff between members of the Sackler family, who own the company, and a group of state attorneys general over how much the family should pay and whether it can continue selling drugs abroad. The Sacklers […]

Read More

Babies Display ‘Werewolf Syndrome’ After Getting Anti-Baldness Drug by Mistake

MADRID — At least 17 children in Spain developed a form of “werewolf syndrome” after they were given medication intended to treat heartburn that was actually used to stop hair loss. The children who took the mislabeled medicine, some of them babies, began growing hair all over their bodies, a rare condition known as hypertrichosis, […]

Read More

Punish Pharma, Not Patients

The decision on Monday by an Oklahoma judge to fine Johnson & Johnson $572 million for its role in the state’s opioid crisis is only the first step in what promises to be years of complex litigation. In ruling that pharmaceutical marketing caused a “public nuisance” by increasing addiction and overdose deaths, Judge Thad Balkman […]

Read More

Big Pharma Is Starting to Pay for the Opioid Crisis. Make Those Payments Count.

In 1998 tobacco manufacturers reached an unprecedented agreement with 46 states, which had sued the companies for engaging in decades of deceptive marketing practices that contributed to an epidemic of tobacco-related illness and death. Over the next 20 years, the industry paid some $125 billion to the states. But two decades later, only a fraction […]

Read More

Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal

The Sackler family would give up ownership of Purdue Pharma, the company blamed for much of the opioid epidemic, and pay $3 billion of their own money under terms of a settlement proposal to resolve thousands of federal and state lawsuits, according to a person familiar with the negotiations. The discussions have been going on […]

Read More